dabigatran etexilate and its Impurities
Dabigatran Etexilate is used to prevent blood clots from forming because of a certain irregular heart rhythm.. Reference standards of Dabigatran Etexilate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Ethyl 3-(3-amino-4-(2-((4-cyanophenyl)amino)-N-methylacetamido)-N-(pyridin-2-yl)benzamido)propanoate
Ethyl 3-(3-amino-4-(2-((4-cyanophenyl)amino)-N-methylacetamido)-N-(pyridin-2-yl)benzamido)propanoate
Catalogue No.:PA 31 0351000
CAS :
1648817-93-9
Molecular Formula : C27H28N6O4
Molecular Weight : 500.56
Dabigatran Etexilate Mesylate - Impurity C (Freebase)
Ethyl 3-[[2-[[4-[(E)-N′-[(2-ethylbutoxy)carbonyl]carbamimidoyl]anilino]methyl]-1-methyl-1Hbenzimidazole-5-carbonyl](pyridin-2-yl)amino]propanoate
Catalogue No.:PA 31 0350030
CAS :
1873316-01-8
Molecular Formula : C34H41N7O5
Molecular Weight : 627.75
Dabigatran Etexilate Mesylate - Impurity E (Freebase)
3-[[2-[[4-[(E)-N′-[(hexyloxy)carbonyl]carbamimidoyl]anilino]methyl]-1-methyl-1Hbenzimidazole-5-carbonyl](pyridin-2-yl)amino]propanoic Acid
Catalogue No.:PA 31 0350050
CAS :
1415506-19-2
Molecular Formula : C32H37N7O5
Molecular Weight : 599.69
Dabigatran Etexilate Mesylate - Impurity F (Freebase)
Ethyl 3-[[2-[[4-[(E)-N′-[[[(2RS)-heptan-2-yl]oxy]carbonyl]carbamimidoyl]anilino]methyl]-1- methyl-1H-benzimidazole-5-carbonyl](pyridin-2-yl)amino]propanoate
Catalogue No.:PA 31 0350060
CAS :
NA
Molecular Formula : C35H43N7O5
Molecular Weight : 641.77
